SCHEMBL19567425

SCHEMBL19567425

CC1(CC#N)CCN(Cc2ccc(SC(F)(F)F)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ ABCB1 P08183 1/20 0.37
▸ ABCC1 P33527 1/20 0.37
▸ PTPRZ1 P23471 2/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ OPRM1 P35372 1/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ IGF1R P08069 2/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ JAK1 P23458 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24093309 0.86 ALDH1A1 (0.44) CHRM4MEN1KMT2AOPRM1LMNA
SCHEMBL20781924 0.85 USP2 (0.36) USP2CHRM4ABCB1ABCC1PTPRZ1
SCHEMBL19567495 0.85 USP2 (0.38) USP2CHRM4ABCB1ABCC1PTPRZ1
SCHEMBL20782313 0.84 CHRM4 (0.36) USP2CHRM4ABCB1ABCC1PTPRZ1
SCHEMBL19567191 0.83 KDM4E (0.54) USP2OPRM1CYP2D6SMN1; SMN2JAK2
SCHEMBL24093457 0.81 ALDH1A1 (0.44) USP2MEN1KMT2AOPRL1ALDH1A1
SCHEMBL24093065 0.80 ALDH1A1 (0.58) CHRM4TSHRLMNAALDH1A1
SCHEMBL24093035 0.80 ALDH1A1 (0.50) USP2MEN1CYP1A2CYP2C9TSHR
SCHEMBL19567217 0.79 USP2 (0.59) USP2MEN1CYP1A2CYP2C9TSHR
SCHEMBL24093376 0.78 OPRM1 (0.57) MEN1CYP1A2CYP2C9TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 — — WO disclosed
Send feedback